印度“格列卫案”判决:解决知识产权及公共健康问题的新路径
发布时间：2018-08-17 08:48
【摘要】：印度最高法院关于格列卫案的判决吸引了国际社会的广泛关注,不仅关系到印度新修改的专利法对药品专利问题的态度,也影响了广大发展中国家低收入患者的药品可得性问题。印度作为公共健康问题较为严重的发展中国家,非常重视公共健康问题的解决,重视对本国制药企业的保护。该案判决为发展中国家解决公共健康问题提供了有益的借鉴,在TRIPs协议框架下,主权国家完全可以在公共健康问题的解决方面做得更多。
[Abstract]:The decision of the Supreme Court of India in the Glebeth case attracted wide attention from the international community, not only in relation to the attitude of India's newly amended patent law to the issue of drug patents, It also affects the availability of drugs for low-income patients in developing countries. As a developing country with serious public health problems, India attaches great importance to the solution of public health problems and the protection of its pharmaceutical enterprises. The decision provides a useful reference for developing countries to solve public health problems. Under the framework of TRIPs, sovereign states can do more to solve public health problems.
【作者单位】： 吉林大学;
【分类号】：D935.1;DD913
，
本文编号：2187094
[Abstract]:The decision of the Supreme Court of India in the Glebeth case attracted wide attention from the international community, not only in relation to the attitude of India's newly amended patent law to the issue of drug patents, It also affects the availability of drugs for low-income patients in developing countries. As a developing country with serious public health problems, India attaches great importance to the solution of public health problems and the protection of its pharmaceutical enterprises. The decision provides a useful reference for developing countries to solve public health problems. Under the framework of TRIPs, sovereign states can do more to solve public health problems.
【作者单位】： 吉林大学;
【分类号】：D935.1;DD913
，
本文编号：2187094
本文链接：https://www.wllwen.com/falvlunwen/falilunwen/2187094.html
